Jieti Wang

899 total citations
24 papers, 582 citations indexed

About

Jieti Wang is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jieti Wang has authored 24 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Immunology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jieti Wang's work include Cancer Immunotherapy and Biomarkers (14 papers), Immune Cell Function and Interaction (11 papers) and Gastric Cancer Management and Outcomes (6 papers). Jieti Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immune Cell Function and Interaction (11 papers) and Gastric Cancer Management and Outcomes (6 papers). Jieti Wang collaborates with scholars based in China. Jieti Wang's co-authors include Chao Lin, Hongyong He, Hao Liu, Ruochen Li, Heng Zhang, He Li, Jiejie Xu, Yun Gu, Hanji Fang and Kunpeng Lv and has published in prestigious journals such as Nature Communications, Annals of Surgery and British Journal of Cancer.

In The Last Decade

Jieti Wang

23 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jieti Wang China 15 344 318 165 147 99 24 582
Hanji Fang China 13 310 0.9× 278 0.9× 151 0.9× 123 0.8× 88 0.9× 20 509
Qinbo Cai China 8 217 0.6× 211 0.7× 155 0.9× 97 0.7× 88 0.9× 17 461
Yoshiki Mizukami Japan 9 468 1.4× 498 1.6× 188 1.1× 89 0.6× 73 0.7× 14 784
Shozo Hojo Japan 10 335 1.0× 269 0.8× 184 1.1× 89 0.6× 80 0.8× 23 612
Yugang Wu China 14 286 0.8× 238 0.7× 113 0.7× 72 0.5× 85 0.9× 28 497
Cristina Migali Italy 12 376 1.1× 198 0.6× 91 0.6× 86 0.6× 66 0.7× 17 511
Jonna Berntsson Sweden 7 361 1.0× 226 0.7× 75 0.5× 99 0.7× 70 0.7× 12 473
Haruhisa Kitano Japan 11 213 0.6× 166 0.5× 263 1.6× 109 0.7× 87 0.9× 16 547
Yoshihisa Arita Japan 6 346 1.0× 237 0.7× 124 0.8× 53 0.4× 49 0.5× 7 461
Hisahito Endo Japan 11 256 0.7× 151 0.5× 206 1.2× 127 0.9× 89 0.9× 30 532

Countries citing papers authored by Jieti Wang

Since Specialization
Citations

This map shows the geographic impact of Jieti Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieti Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieti Wang more than expected).

Fields of papers citing papers by Jieti Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieti Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieti Wang. The network helps show where Jieti Wang may publish in the future.

Co-authorship network of co-authors of Jieti Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jieti Wang. A scholar is included among the top collaborators of Jieti Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieti Wang. Jieti Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Mengyao, Yun Gu, Jieti Wang, et al.. (2025). Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer. British Journal of Cancer. 132(12). 1148–1157.
2.
Gu, Yun, Mengyao Sun, Hanji Fang, et al.. (2024). Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. British Journal of Cancer. 131(8). 1320–1327. 8 indexed citations
3.
Lv, Kunpeng, Mengyao Sun, Hanji Fang, et al.. (2023). Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. Journal for ImmunoTherapy of Cancer. 11(11). e007669–e007669. 15 indexed citations
4.
Gu, Yun, Jieti Wang, Kunpeng Lv, et al.. (2023). Complement receptor C5aR1 blockade reprograms tumor‐associated macrophages and synergizes with anti‐PD‐1 therapy in gastric cancer. International Journal of Cancer. 153(1). 224–237. 14 indexed citations
5.
Liu, Xin, Kunpeng Lv, Jieti Wang, et al.. (2023). C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer. British Journal of Cancer. 129(4). 721–732. 17 indexed citations
6.
Yu, Kuan, Yun Gu, Hanji Fang, et al.. (2022). Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. British Journal of Cancer. 127(9). 1709–1717. 23 indexed citations
7.
Gu, Yun, Jieti Wang, Chao Lin, et al.. (2022). Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy. Cancer Immunology Immunotherapy. 72(5). 1199–1208. 23 indexed citations
8.
Xu, Chang, Hanji Fang, Yun Gu, et al.. (2022). Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer. Cancer Science. 113(12). 4070–4081. 10 indexed citations
9.
He, Xudong, Yifan Cao, Yun Gu, et al.. (2021). Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients. Annals of Surgical Oncology. 28(11). 6439–6450. 20 indexed citations
10.
Fei, Yuchao, Yun Gu, Hanji Fang, et al.. (2021). Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients. Cancer Immunology Immunotherapy. 71(1). 1–11. 8 indexed citations
11.
Wang, Jieti, Ruochen Li, Yifan Cao, et al.. (2021). Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer. Nature Communications. 12(1). 3080–3080. 56 indexed citations
12.
He, Xudong, Yun Gu, Yifan Cao, et al.. (2021). Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer. European Journal of Cancer. 157. 114–123. 20 indexed citations
13.
Xia, Siyu, Yun Gu, Haijian Zhang, et al.. (2021). Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer. OncoImmunology. 10(1). 1975386–1975386. 21 indexed citations
14.
Chen, Ke, Yun Gu, Yifan Cao, et al.. (2021). TIM3+ cells in gastric cancer: clinical correlates and association with immune context. British Journal of Cancer. 126(1). 100–108. 19 indexed citations
15.
Li, Ruochen, Hao Liu, Jieti Wang, et al.. (2020). Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis. British Journal of Cancer. 122(10). 1525–1534. 36 indexed citations
16.
Fang, Hanji, Yun Gu, Yuchao Fei, et al.. (2020). Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response. OncoImmunology. 9(1). 1856468–1856468. 13 indexed citations
17.
Li, Ruochen, Heng Zhang, Yifan Cao, et al.. (2020). Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer. Cancer Immunology Immunotherapy. 69(7). 1327–1336. 23 indexed citations
18.
Lin, Chao, He Li, Jieti Wang, et al.. (2017). CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Cancer Immunology Immunotherapy. 67(2). 261–269. 40 indexed citations
19.
Wang, Jieti, Chao Lin, He Li, et al.. (2017). Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer. OncoImmunology. 6(11). e1353858–e1353858. 40 indexed citations
20.
Wang, Jieti, Yidong Liu, Yuanfeng Yang, et al.. (2016). High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma. Oncotarget. 7(27). 41986–41995. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanji Fang Breakdown of academic impact, for papers by Qinbo Cai Breakdown of academic impact, for papers by Yoshiki Mizukami Breakdown of academic impact, for papers by Shozo Hojo Breakdown of academic impact, for papers by Yugang Wu Breakdown of academic impact, for papers by Cristina Migali Breakdown of academic impact, for papers by Jonna Berntsson Breakdown of academic impact, for papers by Haruhisa Kitano Breakdown of academic impact, for papers by Yoshihisa Arita Breakdown of academic impact, for papers by Hisahito Endo
Rankless by CCL
2026